-
Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop. 2019 Nov 8. doi: 10.3960/jslrt.19021.
Masak Y, Kawabata H, Fujimoto S, Kawano M, Iwaki N, Kotani T, Nakashima A, Kurose N, Takai K, Suzuki R, Aoki S.
-
2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol. 111(1), 155-158.. doi: 10.1007/s12185-019-02780-1.
Masaki Y, Kawabata H, Takai K, Tsukamoto N, Fujimoto S, Ishigaki Y, Kurose N, Miura K, Nakamura S, Aoki S & Japanese TAFRO syndrome research team.
-
The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.Pathol Res Pract. 2019 Oct;215(10):152563. doi: 10.1016/j.prp.2019.152563. Epub 2019 Jul 26.
Kurose N, Guo X, Shioya A, Mizutani KI, Kumagai M, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Nakamura S, Yamada S.
-
An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Pathol Res Pract. 2018 Dec 26. pii: S0344-0338(18)31509-7. doi: 10.1016/j.prp.2018.12.025.
Kurose N, Mizutani KI, Kumagai M, Shioya A, Guo X, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Kida M, Yamada S.
-
Intravascular large B-cell lymphoma involving large blood vessels. Pathol Int. 2019 Feb;69(2):97-103. doi: 10.1111/pin.12751. Epub 2019 Jan 23.
Sato S, Teshima S, Nakamura N, Ohtake T, Kikuchi J, Kishi H, Nomura K, Kurose N, Masaki Y, Tamaru J.
-
A case of osteosarcoma manifesting systemic inflammation and histological features mimicking plasma cell type Castleman disease. Intern Medicine, 2017 Dec;96(50):e9220. doi: 10.1097/MD.0000000000009220.
Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Doai M, Matoba M, Kawanami HI, Kawanami T, Mizuta S, Fukushima T, Mizumaki Y, Yamaguchi M, Masaki Y.
-
Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin. Ann Hematol. 2019 Apr 19. doi: 10.1007/s00277-019-03689-9.
Yamaguchi M, Suzuki R, Miyazaki K, Amaki J, Takizawa J, Sekiguchi N, Kinoshita S, Tomita N, Wada H, Kobayashi Y, Niitsu N, Ando T, Maeda T, Saito B, Matsuoka H, Sakai R, Kubota N, Masaki Y, Kameoka Y, Asano N, Oguchi M, Katayama N.
-
Impaired expression of innate immunityrelated genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD. Mod Rheumatol. 2019 Jul 11:1-7. doi: 10.1080/14397595.2019.1621475.
Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H.
-
Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol. 2019;94:975–983.doi: 10.1002/ajh.25554.
Fujimoto S, Sakai T, Kawabata H, Kurose N, Yamada S, Takai K, Aoki S, Kuroda J, Ide M, Setoguchi K, Tsukamoto N, Iwao-Kawanami H, Kawanami T, Mizuta S, Fukushima T, Masaki Y.
-
on behalf of the Japanese IgG4-Related Disease Working Consortium. IgG4-related disease in the Japanese population:a genome-wide association study. Lancet Rheumatol 2019 August 6, 2019.http://dx.doi.org/10.1016/S2665-9913(19)30006-2
Terao C, Ota M, Iwasaki T, Shiokawa M, Kawaguchi S, Kuriyama K, Kawaguchi T, Kodama Y, Yamaguchi I, Uchida K, Higasa K, Yamamoto M, Kubota K, Yazumi S, Hirano K, Masaki Y, Maguchi H, Origuchi T, Matsui S, Nakazawa T, Shiomi H, Kamisawa T, Hasebe O, Iwasaki E, Inui K, Tanaka Y, Ohshima K, Akamizu T, Nakamura S, Nakamura S, Saeki T, Umehara H, Shimosegawa T, Mizuno N, Kawano M, Azumi A, Takahashi H, Mimori T, Kamatani Y, Okazaki K, Chiba T, Kawa S, Matsuda F,
-
Bortezomib plus dexamethasone versus thalidomide plus dexamethasone for relapsed or refractory multiple myeloma. Cancer Science 2018 DOI:10.1111/cas.13550
Iida S, Wakabayashi M, Tsukasaki K, Miyamoto K, Maruyama D, Yamamoto K, Takatsuka Y, Kusumoto S, Kuroda J, Ando K, Kikukawa Y, Masaki Y, Kobayashi M, Hanamura I, Asai H, Nagai H, Shimada K, Tsukamoto N, Inoue Y, Tobinai K.
-
Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan. Mod Rheumatol.28（1）161-167,2018. doi: 10.1080/14397595.2017.1366093.
Fujimoto S, Koga T, Kawakami A, Kawabata H, Okamoto S, Mizuki M, Yano S, Ide M, Uno K, Yagi K, Kojima T, Mizutani M, Tokumine Y, Nishimoto N, Fujiwara H, Nakatsuka SI, Shiozawa K, Iwaki N, Masaki Y, Yoshizaki K.
-
Sjögren’s syndrome manifesting as clinicopathological features of TAFRO syndrome. A case report. Medicine (Baltimore). 2017 Dec;96(50):e9220. doi: 10.1097/MD.0000000000009220.
Fujimoto S, Kawabata H, Kurose N, Kawanami-Iwao H,
Sakai T, Kawanami T, Fujita Y, Fukushima T, Masaki Y.
-
Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome. Intern Med 15;57(10):1433-1438,2018
Tsurumi H, Fujigaki Y, Yamamoto T, Iino R, Taniguchi K, Nagura M, Arai S, Tamura Y, Ota T, Shibata S, Kondo F, Kurose N, Masaki Y, Uchida S.
-
The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome. Hum Pathol. 2018 Jul;77:130-138. doi: 10.1016/j.humpath.2018.04.001. Epub 2018 Apr 21.
Kurose N, Futatsuya C, Mizutani KI, Kumagai M, Shioya A, Guo X, Aikawa A, Nakada S, Fujimoto S, Kawabata H, Masaki Y, Takai K, Aoki S, Kojima M, Nakamura S, Yamada S.
-
Activities od the Ishikawa Prefectural joint committee of blood transfusion therapy – Appropriate use of albumin products, educational activities and role of pharmacists- . 社会薬学（Jpn J Soc Pharm） 37(1):2-8,2018
Sugita N, Tanaka H, Satou H, Hutaki T, Miyamoto M, Yoneda S, Okamoto A, Taniguchi Y, Yamasita I, Nitta M, Komori M, Shiobara S, Kikuchi S, Takami A, Yamazaki H, Masaki Y.
-
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707.Haematologica. 2017Dec;102(12):2097-2103. doi: 10.3324/haematol.2017.167742. Epub 2017 Sep 29.
Maeda Y, Nishimori H, Yoshida I, Hiramatsu Y, Uno M, Masaki Y, Sunami K, Masunari T, Nawa Y, Yamane H, Gomyo H, Takahashi T, Yano T, Matsuo K, Ohshima K, Nakamura S, Yoshino T, Tanimoto M.
-
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma. Oncologist. 2017 May;22(5):554-560 pii: theoncologist.2016-0260. doi: 10.1634/theoncologist.2016-0260.
Miura K, Konishi J, Miyake T, Makita M, Hojo A, Masaki Y, Uno M, Ozaki J, Yoshida C, Niiya D, Kitazume K, Maeda Y, Takizawa J, Sakai R, Yano T, Yamamoto K, Sunami K, Hiramatsu Y, Kazutoshi Aoyama, Tsujimura H, Murakami J, Hatta Y, Kanno M.
-
The Standard International Prognostic Index for Predicting the Risk of CNS Involvement in DLBCL without Specific Prophylaxis. Leuk Lymphoma. 2018 Jan;59(1):97-104. doi: 10.1080/10428194.2017.1330541.
Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K.
-
Human recombinant Fab fragment from combinatorial libraries of a B cell lymphoma patient recognizes core protein of chondroitin sulfate proteoglycan 4. J Biochem 163(1)61-68,2017. doi.org/10.1093/jb/mvx065
Egami Y, Narushima Y, Ohshima M, Yoshida A, Yoneta N, Masaki Y, Itoh K.
-
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.Mod Rheumatol. 2017 Sep;27(5):849-854. doi: 10.1080/14397595.2016.1259602. Epub 2016 Dec 15.
Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T.
-
Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016 Jun;103(6):686-92. doi: 10.1007/s12185-016-1979-1. Epub 2016 Mar 18.
Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta NI, Fujimoto S, Kawanami HI, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S,Kinoshita T , Aoki S.
-
Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice. Cell Immunol. 2016 May;303:50-4. doi: 10.1016/j.cellimm.2016.03.004. Epub 2016 Mar 21.
Fujita Y, Fujii T, Shimizu H, Sato T, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Kawanami T, Tanaka M, Masaki Y, Fukushima T, Okazaki T, Umehara H, Mimori T.
-
CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease. Biomedical Res (Tokyo) 36(2) 143-153,2015
Satoh-Nakamura T, Kurose N, Kawanami T, Nakamura T, Iwao-Kawanami H, NakajimaA, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Masaki Y.
-
Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig T, Yamamoto M, Zhang W, Chiba T, and Stone JH. International consensus guidance statement on the treatment of IgG4-related disease. Arthritis Rheum 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132.
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari S, Della-Torre E, Frulloni L, Goto H, Hart P, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Lohr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A,
-
Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease. PLoS One. 2015 May 14;10(5):e0126582. doi: 10.1371/journal.pone.0126582. eCollection 2015.
Nakajima A, Masaki Y, Nakamura T, Kawanami T, Ishigaki Y, Takegami T, Kawano M, Yamada K, Tsukamoto N, Matsui S, Saeki T, Okazaki K, Kamisawa T, Miyashita T, Yakushijin Y, Fujikawa K, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tsuboi H, Sumida T, Morimoto H, Sato T, Iwao H, Miki M, Sakai T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H.
-
Prospective clinical study of R-CMD therapy for indolent B-cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group. Medical Oncol (2015) 32:232. DOI 10.1007/s12032-015-0677-9
Sakai T , Masaki Y, Otsuki N, Sakamaki I, Kishi S, Miyazono T, Urasaki Y, Murakami J, Satoh T, Nakamura T, Iwao H, Nakajima A, Kawanami T, Miki M, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Ueda T.
-
A case of probable IgG4-related disease involving the unilateral trigeminal nerve of the cheek region. Oral Radiol (2015) 31:193–198
Yoshida H, Yasuda N, Hayashi T, Tsuji K, Wato M, Gamoh S, Shimizutani K, Akio Tanaka A, Masaki Y, Morita S.
-
IgG4-related disease - Diagnostic methods and therapeutic strategies in Japan- J Clin Exp Hematop 2014,54(2):95-101
Masaki Y, Shimizu H, Nakamura TS, Nakamura T, Nakajima A, Kawanami HI, Miki M, Sakai T, Kawanami T, Fujita Y, Tanaka M, Fukushima T.
-
Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther 2014 Jul 23;16(4):R156. doi: 10.1186/ar4671.
Mizushima I, Inoue D, Yamamoto M, Yamada K, Saeki T, Ubara Y, Matsui S, Masaki Y, Wada T, Kasashima S, Harada K, Takahashi H, Notohara K, Nakanuma Y, Umehara H, Yamagishi M, Kawano M.
